Treatments for unresectable hepatocellular carcinoma: insights from CheckMate 9DW – Authors' reply
We thank Akhil Santhosh and Nihanthy D Sreenath and Liting Zhang and colleagues for their interest in our trial. The CheckMate 9DW trial showed clinically significant overall survival benefit for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback